Selected Publications
Our published research reflects our dedication to evidence-based innovation and continuous learning in the field of biologic and vaccine formulation.
EFFECT OF ALTERNATIVE ALUMINUM ADJUVANTS ON THE ABSORPTION AND IMMUNOGENICITY OF HPV16 L1 VLPS IN MICE
Caulfield MJ, Shi L, Wang S, Wang B, Tobery TW, Mach H, Ahl PL, Cannon JL, Cook JC, Heinrichs J, Sitrin RD
​
Hum Vaccin. 2007 Jul-Aug;3(4):139-45H
IMPROVING THE IMMUNOGENICITY OF A TRIVALENT NEISSERIA MENINGITIDIS NATIVE OUTER MEMBRANE VESICLE VACCINE BY GENETIC MODIFICATION
Zhang L, Wen Z, Lin J, Xu H, Herbert P, Wang XM, Mehl JT, Ahl PL, Dieter L, Russell R, Kosinski MJ, Przysiecki CT
​
Vaccine. 2016 Jul 29;34(35):4250-4256
ACCELERATING VACCINE FORMULATION DEVELOPMENT USING DESIGN OF EXPERIMENT STABILITY STUDIES
Ahl PL, Mensch C, Hu B, Pixley H, Zhang L, Dieter L, Russell R, Smith WJ, Przysiecki C, Kosinski M, Blue JT
J Pharm Sci. 2016 Oct;105(10):3046-3056
HIGH THROUGHPUT DIFFERENTIAL SCANNING FLUORIMETRY (DSF) FORMULATION SCREENING WITH COMPLEMENTARY DYES TO ASSESS PROTEIN UNFOLDING AND AGGREGATION IN PRESENCE OF SURFACTANTS
McClure SM, Ahl PL, Blue JT
Pharm Res. 2018 Mar 5;35(4):81
QUANTITATIVE ANALYSIS OF VACCINE ANTIGEN ADSORPTION TO ALUMINUM ADJUVANT USING AN AUTOMATED HIGH-THROUGHPUT METHOD
Ahl PL, Wang SC, Chintala R, Mensch C, Smith WJ, Wenger M, Blue J
​
PDA J Pharm Sci Technol. 2018 Mar-Apr;72(2):149-162
FTIR SPECTROSCOPY DETECTS INTERMOLECULAR BETA-SHEET FORMATION ABOVE THE HIGH TEMPERATURE T(M) FOR TWO MONOCLONAL ANTIBODIES
Baird G, Farrell C, Cheung J, Semple A, Blue J, Ahl PL
​
Protein J. 2020 Aug;39(4):318-327
APPLYING MICROFLUIDIC MODULATION SPECTROSCOPY IN VACCINE FORMULATION TO IDENTIFY INTERMOLECULAR BETA-SHEET AGGREGATION OF ANTIGENS
Ahl PL, Baird G, Farrell C, Smith WJ, Blue JT, and Wang L
​
American Pharmaceutical Review​ July /August 2020; 23(5):92-95
ANALYTICAL TECHNOLOGY DEVELOPMENT TO MONITOR THE STABILITY OF POLYSACCHARIDE-PROTEIN CONJUGATE VACCINES
W. J. Smith, P. L. Ahl, B. Wang, M. Hamm, R. R. Rustandi, M. A. Winters, et al.
​
Vaccine 2022 Vol. 40 Issue 31 Pages 4182-4189
IMMUNOGENICITY GENERATED BY MRNA VACCINE ENCODING VZV GE ANTIGEN IS COMPARABLE TO ADJUVANTED SUBUNIT VACCINE AND BETTER THAN LIVE ATTENUATED VACCINE IN NONHUMAN PRIMATES
Monslow MA, Elbashir S, Sullivan NL, Thiriot DS, Ahl P, Smith J, Miller E, Cook J, Cosmi S, Thoryk E, Citron M, Thambi N, Shaw C, Hazuda D, Vora KA
​
Vaccine. 2020 Aug 10;38(36):5793-5802
MICROFLUIDIC AND TURBULENT MIXING FOR MRNA VACCINES
P. L. Ahl
​
​Pharmaceutics 2025 Vol.17 Issue 9 Pages 1148-1180